Risk factor
Good trading liquidity
Profitability factor
Very low or no dividends
About
Jiangsu Kanion Pharmaceutical Co., Ltd. is a Chinese pharmaceutical enterprise focused on the research, development, production, and distribution of traditional Chinese medicines. The company's diverse product range targets several therapeutic areas, such as women's health, bone and joint conditions, antiviral treatments, and cardiovascular and cerebrovascular ailments. Founded in 1975, its primary operations are based in Lianyungang, China.
Company Valuation
Considering past and projected metrics, the stock is slightly 'cheaper' than its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EBITD.
Target Price
The average target price of 600557.SS is 15.8 and suggests 27% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to i